eTheRNA has developed a proprietary and integrated set of platform technologies that are overcoming the challenges facing the development of next generation mRNA therapeutics.
— Sachs Associates (@SachsAssociates) August 9, 2022
e-Meet eTheRNA @ #Sachs_BEF
More info at https://t.co/JkmULss5N2#Sachs_BEF #SALSW @eTheRNA_engine pic.twitter.com/bbc0bHdtVp